Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.73 |
| ▸ | LCK | P06239 | 3/20 | 0.73 |
| ▸ | USP2 | O75604 | 3/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.73 |
| ▸ | EGFR | P00533 | 2/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.73 |
| ▸ | FYN | P06241 | 1/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.73 |
| ▸ | HTR2A | P28223 | 1/20 | 0.73 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.73 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.61 |
| ▸ | CTSB | P07858 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.61 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30863848 | 1.00 | SLC7A5 (0.73) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL30863849 | 1.00 | SLC7A5 (0.73) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL28840880 | 1.00 | SLC7A5 (0.73) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL180154 | 1.00 | SLC7A5 (0.73) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL25357608 | 0.89 | SLC7A5 (0.71) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL2558965 | 0.89 | SLC7A5 (0.71) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL30665436 | 0.89 | SLC7A5 (0.71) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL2558959 | 0.89 | SLC7A5 (0.71) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL25357600 | 0.89 | SLC7A5 (0.71) | SLC7A5KDM4EHSD17B10TDP1LCK | |
| SCHEMBL2554990 | 0.89 | SLC7A5 (0.71) | SLC7A5KDM4EHSD17B10TDP1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117843513-B | Preparation method of (S) -3-Carboxytyrosine | 深圳创元生物医药科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117843513-A | Preparation method of (S) -3-Carboxytyrosine | 深圳创元生物医药科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | claimed |
| US-9101662-B2 | Compositions with modulating agents | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-08-11 | — | — | US | claimed |
| US-8795693-B2 | Compositions with modulating agents | FOAMIX LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
| US-7176185-B2 | Short peptide carrier system for cellular delivery of agent | TSRL, INC. (US) | 2007-02-13 | — | — | US | claimed |
| US-7053214-B2 | β-sheet mimetics and composition and methods relating thereto | MYRIAD GENETICS, INC. (US) | 2006-05-30 | — | — | US | claimed |
| US-20050208140-A1 | Short peptide carrier system for cellular delivery of agent | TSRL, INC. | 2005-09-22 | — | — | US | claimed |
| US-6943157-B2 | Reverse-turn mimetics and composition and methods relating thereto | MYRIAD GENETICS, INC. (US) | 2005-09-13 | — | — | US | claimed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | claimed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-0482966-A2 | Stabilised derivatives of fragments of hirudin, their preparation and pharmaceutical preparations | ADIR ET COMPAGNIE (FR) | 1992-04-29 | — | — | EP | claimed |
| US-20250361274-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | PEPTIDREAM INC. (JP) | 2025-11-27 | — | — | US | disclosed |
| EP-4541805-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | PeptiDream Inc. (JP) | 2025-04-23 | — | — | EP | disclosed |
| EP-0308983-A2 | NMR imaging with Mn(II) coordination compositions | SALUTAR, INC. (US) | 1989-03-29 | — | — | EP | disclosed |
| US-4627915-A | SURFACE CONTAINING HYDROPHOBIC MEMBER AND NEGATIVE CHARGE PRODUCING MEMBER | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1986-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208140-A1 | Short peptide carrier system for cellular delivery of agent | SLC43A1, DNPEP, LNPEP | SLC7A5 6/4885KDM4E 4849/4885HSD17B10 4705/4885 |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | CUTA, SLTM, SMO | SLC7A5 4410/4885KDM4E 4432/4885HSD17B10 2443/4885 |
| US-20250361274-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | BMP4, BMP1, BMPR2 | SLC7A5 2541/4885KDM4E 1440/4885HSD17B10 4643/4885 |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | SLC7A5 21/4885KDM4E 4463/4885HSD17B10 3966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.